About ACCELEVIR DIAGNOSTICS LLC
Accelevir is a bioanalytical CRO specializing in integrated immunogenicity and molecular testing for cell and gene therapies, vaccines, and infectious diseases. They provide services from preclinical to Phase 3, with a focus on regulatory compliance and long-term monitoring.
Molecular genomic analysisDigital PCR (dPCR) and assay developmentPre-validated AAV & Lentiviral vector assaysBiodistribution and vector shedding analysisTargeted short & long-read sequencingViral load & variant discovery assaysFunctional immunology and cellular assaysPBMC processing and functional validation
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| PROVIRAL SEQUENCING DRIVEN DEVELOPMENT OF ENHANCED IPDAV2 WITH GLOBAL HIV-1 GROUP M COVERAGE TO SUPPORT WORLDW | Department of Health and Human Services | $2.0M | |
| Federal contract award | Department of Health and Human Services | $300K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ACCELEVIR DIAGNOSTICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.